Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_provenance.
- NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_assertion description "[This study aimed to evaluate whether co-expression of interleukin-3 (IL-3) could enhance the anti-tumor activity of HSV-sr39tk/GCV prodrug gene therapy using a murine TRAMP-C1 prostate tumor model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_provenance.
- NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_assertion evidence source_evidence_literature NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_provenance.
- NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_assertion SIO_000772 23441198 NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_provenance.
- NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_assertion wasDerivedFrom befree-20140225 NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_provenance.
- NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_assertion wasGeneratedBy ECO_0000203 NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP566791.RAx-wSChtb1o-snch5RznB9--yg856JvdjuAoohXKg1l4130_provenance.